Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hydrolysis Control. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN107382875A offers high-purity Rosuvastatin Impurity B synthesis with significant yield improvements and simplified processing for reliable pharmaceutical intermediates supplier partnerships.
Patent CN102675216B details a novel purification process for 4,6-dichloropyrimidine, offering higher purity and yield for pharmaceutical intermediates manufacturing.
Novel hydrolysis method for high-purity gabapentin. Reduces toxic impurities and energy consumption. Ideal for pharma supply chains.
Advanced hydrolysis method for high-purity gabapentin. Reduces toxic impurities and energy consumption. Ideal for API manufacturing scale-up.
Patent CN108047208B reveals a novel acid-hydrolysis method reducing losartan dimer impurities below 0.1%, offering significant cost reduction in pharmaceutical intermediates manufacturing.